Quick Answer
Sigyn Therapeutics, Inc. reported Total Assets of $213.7 thousand for fiscal year 2024.
Sigyn Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $213.7K | -33.6% |
| 2023 | $321.8K | -3.3% |
| 2022 | $332.9K | -53.1% |
| 2021 | $710.3K | +2.3% |
| 2020 | $694.1K | — |
| 2019 | $0.00 | -100.0% |
| 2018 | $862.0K | -58.4% |
| 2017 | $2.07M | +45.1% |
| 2015 | $1.43M | +153.8% |
| 2014 | $562.3K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $135.6K | -68.3% | +161.9% |
| June 30, 2025 | $51.8K | -83.8% | -78.8% |
| March 31, 2025 | $244.3K | -24.4% | +14.3% |
| December 31, 2024 | $213.7K | -33.6% | -50.0% |
| September 30, 2024 | $427.4K | +10.4% | +33.5% |
| June 30, 2024 | $320.2K | -11.5% | -1.0% |
| March 31, 2024 | $323.3K | -51.0% | +0.5% |
| December 31, 2023 | $321.8K | -3.3% | -16.9% |
- Sigyn Therapeutics, Inc. showed a decrease of -33.6% in Total Assets compared to the prior fiscal year.
- Over the 2014–2024 period, Sigyn Therapeutics, Inc.’s total assets has declined by 62.0% (from $562.3 thousand to $213.7 thousand).
- The most recent figure is from Sigyn Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: